News
Tasmanian devil research could help tackle immunotherapy resistance
A cluster of interacting proteins that are active in both human cancers and Tasmanian devil facial tumours, may give clues to how cancers evade the immune system. This early work in cells could one day…
Scientists evaluate cancer risk of US drinking water
Researchers from the Environmental Working Group (EWG) in Washington, DC, used a new approach to analyze cumulative cancer risk due to carcinogens in tap water across the U.S. This study is the first to apply a “cumulative cancer…
Breakthrough in understanding enzymes that make antibiotic for drug-resistant pathogen
Acinetobacter baumannii is a pathogen that causes hospital-acquired infections that are very difficult to treat, because they are resistant to most currently available antibiotics. As one of the World Health Organization’s three critical priority pathogens, new antibiotics…
Disparities in toxic heavy metal exposures correlated with increased risk of breast cancer among minority populations
Among women in Chicago, African Americans and Hispanics were exposed to higher levels of ambient toxic heavy metals compared with non-Hispanic whites, and this increased exposure correlated with increased incidence of breast cancer. Garth Rauscher,…
Discovery of how colorectal cancer drug works will help more patients
Some colorectal cancer patients with a certain gene mutation benefit from a chemotherapy drug called cetuximab, although the mechanism of how this drug worked was unknown. Scientists have combined computational biology with experimental investigations to…